MannKind Corporation (NASDAQ:MNKD) is one of the Best Penny Stocks to Invest In According to Billionaires. MannKind ...

Is MNKD a good stock to buy? We came across a bullish thesis on MannKind Corporation on BioEquity Watch’s Substack. In this ...

Transaction value based on SEC Form 4 weighted average purchase price ($6.01); post-transaction value based on Dec. 17, 2025 market close price ($5.97). MannKind Corporation's key products include ...

Wall Street issued mixed calls on scPharmaceuticals on Monday after MannKind said it would buy the former in a deal that could total $360 million, or approximately $6.35 per share if all milestones ...

(1) Amount represents revenue earned beginning on the scPharma acquisition date of October 7, 2025. Total revenues for the fourth quarter and full year 2025 rose due to increases in revenue from ...

H.C. Wainwright on Tuesday raised its price target on MannKind to $11 from $9 and reiterated its buy rating on the shares, following positive late-stage study results from partner United Therapeutics ...

WESTLAKE VILLAGE, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation(Nasdaq:MNKD) today announced that it has acquired QrumPharma, Inc., a privately held pharmaceutical company developing ...

Shares of MannKind (MNKD +0.47%) were up 15.6% Wednesday morning after the company released first-quarter earnings after the market closed on Tuesday. The company specializes in treating endocrine and ...

Investors weren't pleased with the biotech's bottom-line decline. It also missed the consensus analyst estimate for that metric. 10 stocks we like better than MannKind › MannKind (NASDAQ: MNKD) was a ...

MannKind Corporation reduces debt by $194 million and increases cash position to over $180 million through note exchanges. MannKind Corporation has announced a significant reduction in its debt by ...